Last reviewed · How we verify
Leuprolide (GnRH agonists) — Competitive Intelligence Brief
marketed
GnRH agonist
GnRH receptor (GNRHR)
Oncology; Endocrinology
Small molecule
Live · refreshed every 30 min
Target snapshot
Leuprolide (GnRH agonists) (Leuprolide (GnRH agonists)) — University of Pisa. Leuprolide is a GnRH agonist that initially stimulates, then suppresses gonadotropin release, leading to decreased testosterone and estrogen production.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Leuprolide (GnRH agonists) TARGET | Leuprolide (GnRH agonists) | University of Pisa | marketed | GnRH agonist | GnRH receptor (GNRHR) | |
| Triptorelin (GnRH agonists) | Triptorelin (GnRH agonists) | University of Pisa | marketed | GnRH agonist | GnRH receptor (GNRHR) | |
| Triptorelin pamoate(15mg) | Triptorelin pamoate(15mg) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | marketed | GnRH agonist | GnRH receptor | |
| GnRH agonist trigger | GnRH agonist trigger | Rambam Health Care Campus | marketed | GnRH agonist | GnRH receptor | |
| Zoladex and Casodex | Zoladex and Casodex | AstraZeneca | marketed | GnRH agonist (Zoladex) and androgen receptor antagonist (Casodex) | GnRH receptor (Zoladex); androgen receptor (Casodex) | |
| TRIPTORELIN ACETATE, hCG | TRIPTORELIN ACETATE, hCG | HaEmek Medical Center, Israel | marketed | GnRH agonist | GnRH receptor | |
| GnRH agonist/antagonist | GnRH agonist/antagonist | Memorial Sloan Kettering Cancer Center | marketed | GnRH agonist/antagonist | GnRH receptor |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (GnRH agonist class)
- Takeda · 4 drugs in this class
- Abbott · 3 drugs in this class
- Ipsen · 3 drugs in this class
- Changchun GeneScience Pharmaceutical Co., Ltd. · 3 drugs in this class
- University of Pisa · 2 drugs in this class
- Chong Qing Reproducive and Genetic Institute · 1 drug in this class
- Chesapeake Urology Research Associates · 1 drug in this class
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · 1 drug in this class
- Enteris BioPharma Inc. · 1 drug in this class
- Colorado Center for Reproductive Medicine · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Leuprolide (GnRH agonists) CI watch — RSS
- Leuprolide (GnRH agonists) CI watch — Atom
- Leuprolide (GnRH agonists) CI watch — JSON
- Leuprolide (GnRH agonists) alone — RSS
- Whole GnRH agonist class — RSS
Cite this brief
Drug Landscape (2026). Leuprolide (GnRH agonists) — Competitive Intelligence Brief. https://druglandscape.com/ci/leuprolide-gnrh-agonists. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing